SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Omeros
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
464 28 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
114Adding Four More, Omeros Has Now Unlocked 46 Orphan GPCRs Equals Number of GPCRsHoward Williams-10/24/2012
113OT <What about your fedora?> RKRW, I was wearing a camo headband this mBiotech Jim-10/19/2012
112>>My last name does not start with B.<< Okey dokey, Jim. I wish I Howard Williams-10/18/2012
111What about your fedora?rkrw-10/18/2012
110< Does your last name start with B and do you know a fellow named Alan that hBiotech Jim-10/18/2012
109Jim, I really can't answer that question as I haven't looked at other coHoward Williams-10/18/2012
108How does OMER's PDE10 program differ from all the extensive work that PfizerBiotech Jim-10/18/2012
107Burrill Institutional Research Starts Stock Coverage on Omeros Corp (OMER) OctHoward Williams-10/15/2012
106Omeros Announces Completion Of Enrollment In OMS302 Phase 3 Clinical Trial – ReHoward Williams-10/3/2012
105Investigational New Drug Application Cleared for Omeros' Lead Compound in PDHoward Williams-10/2/2012
104SEATTLE, Sept. 27, 2012 /PRNewswire/ – Omeros Corporation (OMER) today announcedHoward Williams-9/27/2012
103Omeros Awarded NIMH Grant for Development of Orphan GPCR Antibodies SEATTLE, SeHoward Williams-9/19/2012
102The Huntington's Disease Society of America published favorable comments aboHoward Williams-9/8/2012
101Omeros Files Investigational New Drug Application for Lead Compound in PDE10 ProHoward Williams-9/6/2012
100Omeros to Present at the 19th Annual Newsmakers in the Biotech Industry ConferenHoward Williams-9/4/2012
99Five more GPCRs unlocked ***************************************** http://financHoward Williams-8/15/2012
98Cowen initiates coverage ....... "Outperform" ........... http://finaHoward Williams-8/13/2012
97Upcoming presentations/webcasts ************************************************Howard Williams-8/8/2012
96SEATTLE, Aug. 7, 2012 /PRNewswire/ -- Omeros Corporation (OMER), a clinical-stagHoward Williams-8/8/2012
95Enrollment completed for OMS103HP Phase 3 clinical trial SEATTLE, Aug. 8, 2012Howard Williams-8/8/2012
94Omeros Announces Discovery in MASP-2 Program Mechanism of Activation of ComplemeHoward Williams-7/31/2012
93Maxim ..... new $25 price target Maxim Group reiterated their buy rating on sHoward Williams-7/23/2012
92Snippets from page 1 of the 7/18/12 Wedbush report Omeros Corp. (OMER - OUTPERFHoward Williams-7/20/2012
91Good SeekingAlpha article re OMER out this morning ...... seekingalpha.comHoward Williams-7/20/2012
90July 18, 2012, 7:00 a.m. EDT Omeros Successfully Completes Preclinical StudiesHoward Williams-7/18/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News